EUVIMEDEUVIMED entdecken
Crossref

Editor's Memo

Robert Figlin

Kidney Cancer Journal · 2021

DOI: 10.52733/kcj19n2-e1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Cancer Journal, 2021. Verfasst von Robert Figlin.

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

The COVID-19 pandemic has exposed fundamental disparities in the provision of health care across our nation and exacerbated the differences in health outcomes associated with race, socioeconomic and other demographic factors. A silver lining however is that pandemic precarity has inspired tremendous scientific collaboration among clinicians, researchers, and key opinion leaders. In this line, this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO21) which was kicked off virtually on June 4 through June 8, not only celebrated latest breakthroughs in cancer research, treatment and patient care, but also focused on health equity in cancer care. ASCO21’s fitting theme - Health equity “doing right by the patients for whom we care” reflected addressing complex forces and systems that have created disparities in cancer care, treatment, and research and identifying ways to ensure that all patients have access to and benefit from the latest cancer advances and high-quality cancer care.

Zitieren

APA

Figlin, R. (2021). Editor's Memo. Kidney Cancer Journal. https://doi.org/10.52733/kcj19n2-e1

Vancouver

Figlin R. Editor's Memo. Kidney Cancer Journal. 2021. doi:10.52733/kcj19n2-e1

BibTeX
@article{Figlin2021,
  author = {Figlin, Robert},
  title = {Editor's Memo},
  journal = {Kidney Cancer Journal},
  year = {2021},
  doi = {10.52733/kcj19n2-e1}
}
Kostenlos starten →